Conjunctival hyperemia

Also known as: Conjunctival hyperaemia / Conjunctival redness / Hyperaemia of conjunctiva / Conjunctival injection / Hyperemia of conjunctiva / Conjunctival hyperemia (finding)

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB01114	Chlorpheniramine	A histamine-H1 receptor antagonist indicated for the management of symptoms associated with upper respiratory allergies.
DB13158	Clobetasone	A corticosteroid used to treat dry eyes, eczema, and dermatitis.
DB06764	Tetryzoline	An alpha-adrenergic agonist used in the temporary symptomatic relief of discomfort and redness of the eyes due to minor irritations, as well as alleviate nasal congestion.

Drug	Drug Name	Target	Type
DB01114	Chlorpheniramine	Histamine H1 receptor	target
DB01114	Chlorpheniramine	Cytochrome P450 3A4	enzyme
DB01114	Chlorpheniramine	Cytochrome P450 2D6	enzyme
DB01114	Chlorpheniramine	Sodium-dependent serotonin transporter	target
DB01114	Chlorpheniramine	Sodium-dependent noradrenaline transporter	target
DB01114	Chlorpheniramine	Sodium-dependent dopamine transporter	target
DB01114	Chlorpheniramine	Cytochrome P450 3A5	enzyme
DB01114	Chlorpheniramine	Cytochrome P450 3A7	enzyme
DB01114	Chlorpheniramine	Solute carrier family 22 member 2	transporter
DB01114	Chlorpheniramine	Solute carrier family 22 member 1	transporter
DB13158	Clobetasone	Glucocorticoid receptor	target
DB13158	Clobetasone	Cytochrome P450 3A4	enzyme
DB06764	Tetryzoline	Alpha-1 adrenergic receptors	target
DB06764	Tetryzoline	Alpha-2 adrenergic receptors	target

Drug	Drug Name	Phase	Status	Count